Cannabis Acids Improve Glucose Tolerance in Mice, Cutting Liver Fat in UC Riverside Study
Updated
Updated · geneonline · May 12
Cannabis Acids Improve Glucose Tolerance in Mice, Cutting Liver Fat in UC Riverside Study
4 articles · Updated · geneonline · May 12
CBGA, CBDA and CBGVA improved glucose tolerance and reduced liver fat in mice undergoing diet-induced weight loss in a new UC Riverside preclinical study.
Researchers linked those effects to changes in white-fat genes involved in fatty-acid oxidation and thermogenesis, suggesting the compounds help reverse metabolic dysfunction during weight loss.
The work focuses on non-THC cannabis compounds as a possible explanation for why chronic cannabis users often show lower body weight and lower type 2 diabetes risk despite increased appetite.
Earlier UC Riverside findings showed whole-plant cannabis extract improved glucose regulation in obese mice while THC alone did not, reinforcing the idea that non-THC components may drive the metabolic benefit.
If whole-plant cannabis helps mice, why do human studies link it to a higher diabetes risk?
Which 'minor' cannabinoid is the secret key to a new, non-intoxicating diabetes treatment?
Is creating a standardized 'entourage effect' health product even possible with over 100 different cannabinoids?